Boundless Bio, Inc. Common Stock Analysis
| Analyst Ratings |
|
Average Target Price
|
23.00
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-0.74
|
0.00
|
0.00%
|
|
2024-06-30
|
-0.80
|
-0.77
|
0.03
|
3.75%
|
|
2024-03-31
|
-0.55
|
-12.27
|
-11.72
|
-2130.91%
|
|
2019-09-30
|
-1.07
|
-1.00
|
0.07
|
6.54%
|
|
2019-06-30
|
-1.04
|
-1.01
|
0.03
|
2.88%
|
|
2019-03-31
|
-0.89
|
-1.13
|
-0.24
|
-26.97%
|
|
2018-12-31
|
-0.91
|
-0.84
|
0.07
|
7.69%
|
|
2018-09-30
|
-0.88
|
-0.97
|
-0.09
|
-10.23%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-16.92
|
|
2018-12-31
|
-3.40
|
|
2017-12-31
|
-3.40
|
|
2016-12-31
|
-8.28
|